STOCK TITAN

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Rhea-AI Summary

Neuronetics (STIM) granted 9,000 restricted stock units to Julia Roussel, a non-executive employee, as an inducement to join the company. The Compensation Committee approved the award under Nasdaq Listing Rule 5635(c)(4), and the award is subject to the company's 2020 Inducement Incentive Plan. One-third of the award vests on each of the first three grant anniversaries, provided Roussel remains employed by Neuronetics through the applicable vesting date.

Loading...
Loading translation...

Positive

  • None.

Negative

  • Minor point. Forward-looking: it has not happened yet and may not happen.9,000 restricted stock units represent potential dilution for existing shareholders, with vesting tied to continued employment.

Key Figures

Inducement RSUs: 9,000 RSUs Vesting schedule: 1/3 on each of the first, second and third anniversaries
Inducement RSUs
9,000 RSUs
Granted to one non-executive employee
Vesting schedule
1/3 on each of the first, second and third anniversaries
Subject to continued employment through each vesting date

Historical Context

1 past event · Latest: Nov 04
1 event
  1. Nov 04

    inducement grant

    24h Move
    -10.2%

    Fourteen employees received RSUs under the same 2020 plan, with staged vesting and continued-service conditions.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

nasdaq listing rule 5635(c)(4), restricted stock units
2 terms
nasdaq listing rule 5635(c)(4) regulatory
"In accordance with NASDAQ Listing Rule 5635(c)(4)"
NASDAQ Listing Rule 5635(c)(4) is a rule that requires a company to get approval from its shareholders before selling a large amount of its shares, usually over 20%. This helps protect investors by making sure the company doesn't flood the market with new shares without their say, which could lower the stock's value.
restricted stock units financial
"Restricted stock units (“RSUs”)"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

MALVERN, Pa., Nov. 18, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health and provider of NeuroStar® TMS technology and direct patient care through the Greenbrook network of interventional psychiatry clinics, today announced the granting of inducement award(s) to one non-executive employee as described below. In accordance with NASDAQ Listing Rule 5635(c)(4), this award was approved by Neuronetics’ Compensation Committee and made as a material inducement to their respective employment with the Company. In all cases, vesting is subject to the recipient’s continued service with the Company through the applicable vesting date, and the awards are subject to the terms of the Company’s 2020 Inducement Incentive Plan.

Restricted stock units (“RSUs”) 

Name Number of Inducement
Plan RSUs 
Vesting Schedule 
Julia Roussel9,0001/3 on first anniversary of grant date; 1/3 on second anniversary of grant date; 1/3 on third anniversary of grant date, subject in each case to the recipient’s continued employment by the Company through the applicable vesting date.
 

About Neuronetics
Neuronetics, Inc. is a leader in interventional mental health, combining innovative treatment technologies with direct patient care. Through its NeuroStar® Advanced Therapy system, the company is a leading provider of transcranial magnetic stimulation (TMS) treatment and, through Greenbrook, operates one of the largest interventional psychiatry clinic networks in the United States, offering both TMS and SPRAVATO® therapies. NeuroStar Advanced Therapy is a non-drug, noninvasive treatment that can improve the quality of life for people suffering from neurohealth conditions when traditional medication has not helped. NeuroStar Advanced Therapy is the leading TMS treatment for MDD in adults and is backed by what we believe is the largest clinical data set of any TMS treatment system for depression. Greenbrook treatment centers also offer SPRAVATO® (esketamine) Nasal Spray, a prescription medicine indicated for the treatment of treatment-resistant depression (“TRD”) in adults as monotherapy or in conjunction with an oral antidepressant. It is also indicated for depressive symptoms in adults with MDD with acute suicidal ideation or behavior in conjunction with an oral antidepressant.1

The NeuroStar Advanced Therapy System is cleared by the U.S. Food and Drug Administration for adults with MDD, as an adjunct for adults with obsessive-compulsive disorder, to decrease anxiety symptoms in adult patients with MDD that may exhibit comorbid anxiety symptoms (anxious depression), and as a first line adjunct for the treatment of MDD in adolescent patients aged 15-21. For safety information and indications for use, visit NeuroStar.com.

Neuronetics Contact:
Investors:
Mark Klausner or Aman Patel
ICR Healthcare
443-213-0499
ir@neuronetics.com

Media:
EvolveMKD
646.517.4220
NeuroStar@evolvemkd.com

References
1 The effectiveness of SPRAVATO® in preventing suicide or in reducing suicidal ideation or behavior has not been demonstrated. Use of SPRAVATO® does not preclude the need for hospitalization if clinically warranted, even if patients experience improvement after an initial dose of SPRAVATO®. For more important safety information about SPRAVATO®, please visit spravatohcp.com.


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Who received the Neuronetics (STIM) inducement grant, and how large was it?

Neuronetics granted 9,000 restricted stock units to Julia Roussel, one non-executive employee, as an employment inducement.

When do the restricted stock units in Neuronetics’ inducement grant vest?

The units vest one-third on each of the first three grant anniversaries, provided Roussel remains employed by Neuronetics through each applicable vesting date.

Keep reading